First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients

被引：0
|
作者：
Jee-Fu Huang
Chia-Yen Dai
Chung-Feng Huang
Pei-Chien Tsai
Ming-Lun Yeh
Po-Yau Hsu
Shiu-Feng Huang
Ming-Jong Bair
Nai-Jen Hou
Ching-I Huang
Po-Cheng Liang
Yi-Hung Lin
Chih-Wen Wang
Ming-Yen Hsieh
Shinn-Chern Chen
Zu-Yau Lin
Ming-Lung Yu
Wan-Long Chuang
机构：
[1] Kaohsiung Medical University Hospital,Hepatobiliary Division and Hepatitis Center, Department of Internal Medicine
[2] Kaohsiung Medical University,Graduate Institute of Clinical Medicine
[3] Kaohsiung Medical University,Faculty of Internal Medicine, College of Medicine
[4] Kaohsiung Medical University,Center for Liquid Biopsy and Cohort Research
[5] Kaohsiung Medical University,Department of Internal Medicine, Kaohsiung Municipal Ta
[6] National Health Research Institutes,Tung Hospital
[7] Linko Chang Gung Memorial Hospital,Institute of Molecular and Genomic Medicine
[8] Taitung Mackay Memorial Hospital,Department of Anatomic Pathology
[9] Mackay Medical College,Division of Gastroenterology, Department of Internal Medicine
来源：
Hepatology International | 2021年 / 15卷
关键词：
Non-alcoholic steatohepatitis; Insulin sensitizer; Insulin resistance; Steatosis; Liver inflammation; Fibrosis; Magnetic resonance imaging–proton density fat fraction; Asians; Clinical trial; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1136 / 1147
页数：11
相关论文
共 50 条
  • [1] First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
    Huang, Jee-Fu
    Dai, Chia-Yen
    Huang, Chung-Feng
    Tsai, Pei-Chien
    Yeh, Ming-Lun
    Hsu, Po-Yau
    Huang, Shiu-Feng
    Bair, Ming-Jong
    Hou, Nai-Jen
    Huang, Ching-, I
    Liang, Po-Cheng
    Lin, Yi-Hung
    Wang, Chih-Wen
    Hsieh, Ming-Yen
    Chen, Shinn-Chern
    Lin, Zu-Yau
    Yu, Ming-Lung
    Chuang, Wan-Long
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1136 - 1147
  • [2] The first double-blind randomized placebo-controlled phase 2 study to assess the efficacy and safety of insulin sensitizer in patients with non-alcoholic steatohepatitis in Asia- an interim report
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Tsai, Pei-Chien
    Huang, Ching-I
    Dai, Chia-Yen
    Chen, Shinn-Chern
    Huang, Jee-Fu
    Yu, Ming-Lung
    Chuang, Wan-Long
    JOURNAL OF HEPATOLOGY, 2020, 73 : S449 - S449
  • [3] Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
    Harrison, Stephen A.
    Neff, Guy
    Guy, Cynthia D.
    Bashir, Mustafa R.
    Paredes, Angelo H.
    Frias, Juan P.
    Younes, Ziad
    Trotter, James F.
    Gunn, Nadege T.
    Moussa, Sam E.
    Kohli, Anita
    Nelson, Kristin
    Gottwald, Mildred
    Chang, William C. G.
    Yan, Andrew Z.
    DePaoli, Alex M.
    Ling, Lei
    Lieu, Hsiao D.
    GASTROENTEROLOGY, 2021, 160 (01) : 219 - +
  • [4] Hepatoprotective Effect ofAntrodia cinnamomeaMycelium in Patients with Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial
    Chiou, Ya-Ling
    Chyau, Charng-Cherng
    Li, Tsung-Ju
    Kuo, Chia-Feng
    Kang, Yu-Yling
    Chen, Chin-Chu
    Ko, Wang-Sheng
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2021, 40 (04) : 349 - 357
  • [5] A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism
    Sahney, Amrish
    Sharma, Barjesh Chander
    Jindal, Ankur
    Anand, Lovkesh
    Arora, Vinod
    Vijayaraghavan, Rajan
    Dhamija, Ravinder Mohan
    Kumar, Guresh
    Bhardwaj, Ankit
    Sarin, Shiv Kumar
    LIVER INTERNATIONAL, 2019, 39 (04) : 684 - 693
  • [6] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
    V. Ratziu
    L. de Guevara
    R. Safadi
    F. Poordad
    F. Fuster
    J. Flores-Figueroa
    M. Arrese
    Anna L. Fracanzani
    D. Ben Bashat
    K. Lackner
    T. Gorfine
    S. Kadosh
    R. Oren
    M. Halperin
    L. Hayardeny
    R. Loomba
    S. Friedman
    Arun J. Sanyal
    Nature Medicine, 2021, 27 : 1825 - 1835
  • [7] Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
    Ratziu, V.
    de Guevara, L.
    Safadi, R.
    Poordad, F.
    Fuster, F.
    Flores-Figueroa, J.
    Arrese, M.
    Fracanzani, Anna L.
    Ben Bashat, D.
    Lackner, K.
    Gorfine, T.
    Kadosh, S.
    Oren, R.
    Halperin, M.
    Hayardeny, L.
    Loomba, R.
    Friedman, S.
    Sanyal, Arun J.
    NATURE MEDICINE, 2021, 27 (10) : 1825 - +
  • [8] Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome
    Weerts, Zsa Zsa R. M.
    Masclee, Ad A. M.
    Witteman, Ben J. M.
    Clemens, Cees H. M.
    Winkens, Bjorn
    Brouwers, Jacobus R. B. J.
    Frijlink, Henderik W.
    Muris, Jean W. M.
    De Wit, Niek J.
    Essers, Brigitte A. B.
    Tack, Jan
    Snijkers, Johanna T. W.
    Bours, Andrea M. H.
    de Ruiter-van der Ploeg, Annieke S.
    Jonkers, Daisy M. A. E.
    Keszthelyi, Daniel
    GASTROENTEROLOGY, 2020, 158 (01) : 123 - 136
  • [9] Safety and Efficacy of Avacopan in Patients with Complement 3 Glomerulopathy Randomized, Double-Blind Clinical Trial
    Bomback, Andrew S.
    Herlitz, Leal C.
    Kedia, Priyanka Punit
    Petersen, Jeffrey
    Yue, Huibin
    Lafayette, Richard A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025, 36 (03): : 487 - 499
  • [10] The efficacy and safety of ciprofol and propofol in patients undergoing colonoscopy: A double-blind, randomized, controlled trial
    Gao, Shi-Hui
    Tang, Qian-Qian
    Wang, Chang-Ming
    Guan, Zhan-Ying
    Wang, Ling-Ling
    Zhang, Jing
    Yan, Zeng-Long
    JOURNAL OF CLINICAL ANESTHESIA, 2024, 95
12345